Latest news
Biopharma industry faces public trust, communication challenges - BioProcess InternationalBioProcess International · Thu, 06 Aug 2026 00:11:19 GMTPoor planning hampers cell and gene therapy firms, expert says - BioProcess InternationalBioProcess International · Wed, 05 Aug 2026 23:21:29 GMTCell Summit 2026: Expanding global access to gene therapies - BioProcess InternationalBioProcess International · Wed, 05 Aug 2026 00:15:53 GMTSouth Korea IIT: The Emerging Global Alternative for Accelerating Cell & Gene Therapy Development - BioProcess InternationalBioProcess International · Tue, 04 Aug 2026 21:59:26 GMTGenetic clues for cell therapy toxicities; Summit’s high-stakes FDA decision - Pharma VoicePharma Voice · Fri, 31 Jul 2026 13:20:07 GMT